George M Cannon
Overview
Explore the profile of George M Cannon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Swords D, Skarda D, Sause W, Gawlick U, Cannon G, Lewis M, et al.
J Gastrointest Surg
. 2019 Feb;
23(4):659-669.
PMID: 30706375
Introduction: Neoadjuvant therapy (NT) is the standard of care for clinical stage II-III rectal adenocarcinoma, but utilization remains suboptimal. We aimed to determine the underlying reasons for omission of local...
2.
Torgeson A, Garrido-Laguna I, Tao R, Cannon G, Scaife C, Lloyd S
ESMO Open
. 2018 Feb;
3(1):e000282.
PMID: 29387477
Background: Surgical resection remains the best chance at long-term survival in pancreatic cancer, though margin-positive resections are associated with diminished survival. We examined the effect of margin-positive resection on survival,...
3.
Torgeson A, Lloyd S, Boothe D, Tao R, Whisenant J, Garrido-Laguna I, et al.
Cancer
. 2017 Jun;
123(19):3816-3824.
PMID: 28621885
Background: The role of chemoradiotherapy (CRT) in locally advanced pancreatic cancer (LAPC) is uncertain after multiple randomized clinical trials have yielded mixed results. The authors used the National Cancer Data...
4.
Bagshaw H, Sause W, Gawlick U, Tae Kim H, Whisenant J, Cannon G
Am J Clin Oncol
. 2016 Jul;
41(5):492-496.
PMID: 27438690
Objectives: The objective is to determine localregional control (LRC), distant metastasis free survival, disease-free survival, overall survival (OS), and toxicity for patients with squamous cell carcinoma of the anus treated...
5.
Cannon D, Mehta M, Adkison J, Khuntia D, Traynor A, Tome W, et al.
J Clin Oncol
. 2013 Oct;
31(34):4343-8.
PMID: 24145340
Purpose: Local failure rates after radiation therapy (RT) for locally advanced non-small-cell lung cancer (NSCLC) remain high. Consequently, RT dose intensification strategies continue to be explored, including hypofractionation, which allows...
6.
Cannon D, McHaffie D, Patel R, Adkison J, Das R, Anderson B, et al.
Ann Surg Oncol
. 2013 May;
20(11):3446-52.
PMID: 23709055
Background: Understanding risk factors for locoregional recurrence (LRR) after accelerated partial breast irradiation (APBI) can help to guide patient selection for treatment with APBI. Published findings to date have not...
7.
Kruser T, McCabe B, Mehta M, Khuntia D, Campbell T, Geye H, et al.
Am J Clin Oncol
. 2013 Jan;
37(1):70-6.
PMID: 23357968
Objectives: To our knowledge this is the largest report analyzing outcomes for re-irradiation (reRT) for locoregionally recurrent lung cancer, and the first to assess thoracic reRT outcomes in patients with...
8.
Vogelius I, Westerly D, Aznar M, Cannon G, Korreman S, Mackie T, et al.
Acta Oncol
. 2011 Jul;
50(6):772-6.
PMID: 21767173
Background: Traditionally, radiation therapy plans are optimized without consideration of chemotherapy. Here, we model the risk of radiation pneumonitis (RP) in the presence of a possible interaction between chemotherapy and...
9.
Vogelius I, Westerly D, Cannon G, Mackie T, Mehta M, Sugie C, et al.
Int J Radiat Oncol Biol Phys
. 2011 Apr;
80(3):893-9.
PMID: 21477946
Purpose: To model the possible interaction between cytotoxic chemotherapy and the radiation dose distribution with respect to the risk of radiation pneumonitis. Methods And Materials: A total of 18 non-small-cell...
10.
Schubert L, Gondi V, Sengbusch E, Westerly D, Soisson E, Paliwal B, et al.
Radiother Oncol
. 2011 Feb;
100(2):241-6.
PMID: 21316783
Background And Purpose: To compare left-sided whole breast conventional and intensity-modulated radiotherapy (IMRT) treatment planning techniques. Materials And Methods: Treatment plans were created for 10 consecutive patients. Three-dimensional conformal radiotherapy...